MD Anderson designated first Project ECHO superhub for oncology

February 10, 2017

HOUSTON ― Recognizing a critical need to address disparities in cancer care, The University of Texas MD Anderson Cancer Center has been designated as an ECHO superhub for oncology by the ECHO Institute at the University of New Mexico Health Science Center (UNMHSC). MD Anderson is one of just nine ECHO superhub sites in the world and the first focused on oncology.

Project ECHO (Extension for Community Healthcare Outcomes) was developed in 2003 to expand local capacity to provide specialty treatments for hepatitis C patients in rural New Mexico. The telementoring ECHO model connects primary care physicians from rural and underserved areas with specialists from academic medical centers to share best-practice management of complex health conditions.

As an ECHO superhub, MD Anderson will collaborate with and train other academic cancer centers interested in using the telementoring ECHO model to improve patient access to high-quality care in rural and underserved areas around the world. The new designation was announced today at MD Anderson by its founder, Sanjeev Arora, M.D., director of Project ECHO at UNMHSC.

"We believe that the ECHO model has great potential to promote greater equity in care delivery across the entire cancer spectrum," said Ernest Hawk, M.D., vice president and head, Division of Cancer Prevention and Population Sciences. "As we build a global partner network of academic and local health care providers through Project ECHO, we will establish projects to improve the capacity for local providers to provide high-quality cancer prevention, screening, and treatment options in their communities."

Currently, Project ECHO works with 109 partners across the United States and 21 other countries on more than 55 different medical conditions. MD Anderson first established an oncology-focused ECHO program in 2014 with a project aimed at improving cervical cancer prevention, screening and management services in Texas' Rio Grande Valley.

In this underserved region along the Texas-Mexico border, cervical cancer rates are as much as 30 percent higher than the rest of the state, primarily due to poor health care access and few local providers trained in cervical cancer management. MD Anderson faculty use the ECHO model to mentor local providers in educating women about the importance of screening and vaccination for the human papillomavirus (HPV), as well as best practices for screenings, diagnostics and early cancer management.

MD Anderson has now established a series of ECHO partnerships across Texas, Latin America and Africa to address needs in tobacco cessation, survivorship and palliative care in addition to cancer prevention, screening and management.

"Through participation in ECHO projects, local providers report both improved knowledge and ability to deliver high-quality care in their communities," said Kathleen Schmeler, M.D., associate professor, Gynecologic Oncology and Reproductive Medicine. "These rewarding partnerships also foster ongoing collaborative projects and work toward long-term solutions to disparities in cancer care. We hope establishing a broader global network of ECHO partners for oncology will further accelerate our mission."

Schmeler and Hawk will serve as directors of the MD Anderson ECHO superhub, which is managed by the cancer prevention and control platform, part of MD Anderson's Moon Shots Program™, an ambitious effort to reduce cancer deaths by more rapidly developing and implementing advances in prevention, early detection and treatment based on scientific discoveries. The program comprises 13 moon shots focused on a variety of the most challenging cancers backed by 10 platforms that provide deep expertise, cutting-edge technology and infrastructure.

University of Texas M. D. Anderson Cancer Center

Related Palliative Care Articles from Brightsurf:

Palliative care needed across China for everyone who needs it -- study
Palliative care should extend across China and pay more attention to managing non-malignant disease -- integrated within the country's healthcare system and available to everyone who needs it, according to a new study.

New palliative care model shown to reduce costs without compromising on quality of care
Findings from a large-scale clinical trial testing a new palliative care model have shown to be lower cost, viewed positively by patients and their carers while showing no difference in patient-reported outcomes when compared with standard care.

Palliative Care in emergency departments during COVID-19 pandemic
The clinical characteristics and outcomes of patients who received intervention by a COVID-19 palliative care response team are examined in this case series.

Palliative care for patients with cancer in COVID-19 era
The considerations and challenges affecting the palliative care specialty and delivery of palliative care in the COVID-19 era, as well as potential solutions, are discussed in this Viewpoint.

To face coronavirus disease 2019, surgeons must embrace palliative care
This Viewpoint describes the relevance of a palliative care approach to surgery during the coronavirus disease 2019 pandemic.

Call for palliative care to be adapted for severely ill Covid-19 patients
Emergency-style palliative care needs to implemented to meet the needs of Covid-19 patients who wouldn't benefit from a ventilator say researchers.

A COVID-19 palliative care pandemic plan: An essential tool
Palliative care physicians have created a coronavirus disease 2019 (COVID-19) palliative care plan as an essential tool to provide care and help manage scare resources during the pandemic.

MAiD is not driven by socioeconomic vulnerability or poor access to palliative care
A new study of people who received medical assistance in dying (MAiD) in Ontario found that about three-quarters were cared for by palliative care practitioners at the time of their request for MAiD, and MAiD recipients were younger, wealthier and more likely to be married than the general population at time of death.

Palliative vs. standard care for Parkinson's disease
This randomized clinical trial that included 210 patients with Parkinson's disease and related disorders and 175 caregivers examined whether outpatient palliative care was associated with better patient or caregiver outcomes compared with standard care.

Palliative care in hospitals linked to decrease in use of ICU; treatment intensity
A new study shows that implementing hospital-based palliative care services in New York State reduces treatment intensity at the end of life for hospitalized patients.

Read More: Palliative Care News and Palliative Care Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to